WORLDWIDE PRESENCE

Swiss Garnier, by leveraging on its vast experience, technological strength and product quality, has now spread its wings to over 40 countries across the globe.

The plant is PIC/S accredited and as various international approvals.

The division is backed by a strong and highly committed regulatory affairs team to provide documentation support of international standard. We have more than 120 CTD/ ACTD dossiers and have filed close to 400 registrations across the globe.

Established in 2014, the company’s International Division has grown by leaps & bound. And it is present across Asia, Africa, LATAM & Europe. Continuously expanding year on year.

With an annual growth of more than 100% during the last years, the company’s International division is projected to contribute at least 40% of the company’s revenue within the next few years.

SWISS GARNIER closely monitors worldwide markets to identify the products that become off-patent from time to time and are of great importance to the global healthcare community.

At the same time, market research projects are often carried outto enable the company to enter new markets.

Our success is based on our unique combination of strategic advantages:

  • Voglibose mouth dissolving tablets
  • Growth of production capacity via the continuous investment in state-of-the-art technology.
  • Rapid expansion of our product portfolio.
  • Continuous & careful investment in human resources.
  • Willingness of our highly educated personnel to provide support regarding the use of our products.
  • Open, honest & timely communication with our partners worldwide.
  • On-time distribution and product delivery.
  • Immediate supply of any extra and urgent needs.
  • A clearly defined corporate philosophy based on the principles of quality, growth, professional & flexible management and financial independence.
    • Top